India, Oct. 29 -- Shares of several healthcare companies moved higher following quarterly financial results and business updates. Glaukos raised its 2026 sales guidance and issued a preliminary outlook for 2027, Teladoc Health reported improved adjusted EBITDA, Bausch Health posted higher revenue and earnings, and Mesoblast reported strong Ryoncil revenue growth alongside clinical and regulatory developments.
Read on.....
Glaukos Corp. (GKOS)
Shares of Glaukos surged 33% after third-quarter 2026 net sales rose 58% to $211.03 million, with the company swinging to net income of $2 million from a year-earlier loss of $16.2 million. Glaukos raised its 2026 sales guidance to $775 million-$785 million and forecast preliminary 2027 sales of $1 ...